The table below shows Xenon Pharmaceuticals Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$7.50M
$0.00
$0.00
$9.43M
$18.44M
$32.17M
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$300.94M
$210.39M
$167.51M
$105.77M
$75.46M
$50.52M
SG&A
$79.63M
XENE annual revenue (10-K history)
Xenon Pharmaceuticals Inc. reported annual revenue of $7.50M for fiscal year 2025. Over the 10 fiscal years shown, annual revenue declined from $15.58M (FY 2015) to $7.50M. Figures come from the company's audited annual reports as filed with the SEC.